EFCC has six Committees (C) which carry out their tasks via Working Groups (WG) or Task-andFinish Groups (TFG). The current structure and a detailed description of key activities are described on EFCC's website (www.efcclm.eu -About the EFCC -Structure 
KEY ACTIVITIES
The EFCC had a very busy year of fulfilling all the ambitions of its strategic goals and organizing the numerous tasks that were set out in its Action Plan [2] . Key activities and achievements in 2010 are summarised below.
ORGANIZATION AND LIAISON
− The relationship and collaboration with IFCC was strengthened and formalised by signing the IFCC-EFCC Memorandum of Understanding and Working Agreement [3] .
− IFCC and EFCC revised jointly the Euromedlab guidelines [4] , and sent out a call for applications for the 2015 conference. − EFCC signed an agreement of collaboration with EQALM (European Committee for External Quality Assurance Programmes in Laboratory Medicine) and the first joint EFCC-EQALM meeting was held in Lisbon during the 1 st EFCC-UEMS Conference.
SCIENTIFIC COMMITTEE
-The Cardiac Marker WG has performed a European collaborative survey in 2009-2010 and presented the results in Lisbon in a session entitled "How to evaluate cardiovascular risk?" A publication on the survey findings is being prepared. The WG will also present its findings at the Worldlab/Euromedlab 2011 in Berlin.
-The Biological Variation WG developed a web site and a biological variation data simulation package has been published on this site (www.biologicalvariation.com/Tools.html) that allows users to look at the impact of varying biological variation data upon analytical goals, performance characteristics and reference change values.
-The Guidelines WG carried out research on and develops laboratory guidelines for reflective testing. The WG created a website (www.reflectivetesting.com) which is being translated to English. The WG carries out research into the quality of guidelines with the intention to formulating recommendations for making guidelines for laboratory testing [7] [8] [9] [10] . The WG contacted the European Task Force guidelines for cardiovascular disease prevention at the European Atherosclerosis Society and the European Society of Cardiology about potential involvement in joint guideline initiatives.
-The Postanalytical EQAS WG is involved in international case vignette-based surveys on how general practitioners use and interpret laboratory test results and whether they follow evidencebased guideline recommendations in practice. Results of a former survey on microalbuminuria testing were published in 2010. [11] . A new postanalytical external quality assessment scheme was set up for for prothrombin time-INR monitoring and sent to doctors in 14 different countries in spring 2010. The project is carried out in cooperation with EFCC and EQALM. Results will be published in 2011.
-The Test Evaluation WG held its first meeting in October 2010 in Lisbon. The group is preparing a scoping paper on biomarker evaluation and prepares an evidence based framework and supporting tools for testing the clinical effectiveness of diagnostic biomarkers for different applications. Some elements of the work have been presented at the Bergmeyer Conference in March 2010 and published in the conference proceedings [12] . The WG will present a session on test Evaluation at the Worldlab/Euromedlab Congress in 2011 in Berlin. The group's activity is supported by Roche and it is collaboration between EFCC and AACB.
-The Creatinine Standardisation WG aims to improve assay standardisation and to create an inventory of publications about problems related to creatinine standardisation. A position paper was submitted by the WG in 2010, which was accepted for publication [13] .
-A Preanalytical TFG was was established and prepares the 1 st EFCC-BD European Preanalytical Conference on 1-2 April 2011 in Parma, Italy (http://www.preanalyticalphase.org/). An opinion paper co-authored by all invited speakers was submitted to CCLM and will be published in April 2011.
-The Science Committee delegated C Cobbaert to the AACC harmonization meeting. Conference report was published in EFCC News [6] . Proposals were made for a new WG on Harmonization which will be established in 2011 and will collaborate with similar groups at AACC and IFCC.
-The SPIDIA Project Group is involved in an EU collaborative project on the standardization of the preanalytical phase in molecular biology testing (www.spidia.eu). The EFCC contributed to the development and implementation of the web site for the SPIDIA applications. Within the framework of the project a ring-trial across Europe has been accomplished. Preliminary results were published in EFCC News [14] .
-For lack of EU funding, the EUMETALAB project group was terminated in 2010.
-Science Committee members collaborate with the IFCC POCT committee and will deliver a session at the Berlin Worldlab/Euromedlab Congress.
-The Science Committee chair was heavily engaged in developing the highly successful scientific program and the interactive sessions of the 1 st EFCC-UEMS Congress in Lisbon. The Committee was also responsible for putting together the scientific program of the 1 st European Preanalytical Conference to be held in Parma.
-Members of the Committee have been involved in the promotion evaluation of the applications of the EFCC-Abbott Labs-are-Vital Award for excellence in outcomes research which will be first awarded at the Berlin Worldlab/Euromedlab Congress [6] .
EDUCATION AND TRAINING COMMITTEE
− The highlight of the year was the 1 st EFCC-UEMS European Conference on Laboratory Medicine in Healthcare on 13-16 October in Portugal, Lisbon. The full report can be viewed on the EFCC website and in EFCC's January 2011 . The 2 nd European Conference will be held in Croatia in 2012.
− The key educational event was the 10th anniversary of the EFCC Continuous Postgraduate
Course in Clinical Chemistry on "New trends in classification, diagnosis and management of thrombophilia", held on 23-24 October 2010 in Dubrovnik, Croatia. This course was jointly organised with the European Thrombosis Research Organisation (ETRO) and a special issue of CCLM Journal was dedicated to review articles of the course, which was freely circulated to National Society membership [15] . The 11th EFCC Continuous Postgraduate Course will be on 22-23 October 2011 and will deal with the topic of inflammation.
− On October 4-9, 2010, Belgrade hosted the 17th Congress of Medical Biochemistry and Laboratory Medicine marking the 55th anniversary of the Serbian national society and held under the auspices of the IFCC, EFCC, BCLF. Simultaneously the 6th EFCC Symposium for the Balkan Region also took place, with a key focus on "Implementing Laboratory Automation, Quality and Efficiency" [6] .
− The 18th Meeting of the Balkan Clinical Laboratory Federation in conjunction with the 3rd Albanian National Conference of Clinical Biochemistry and Laboratory Medicine, was held on 22-25 September, 2010 in Tirana [14] .
− EFCC was represented in the Scientific Advisory Board of Worldlab and Euromedlab 2011. EFCC officers actively took part in shaping the program of this conference where four EFCC sessions will be presented.
− The Committee developed the EFCC auspices' policy and is working on establishing a system of EU CME crediting.
− The Distance and e-Learning WG organised the 2 nd Symposium on Accreditation sponsored by BioRad, on the last day of the Lisbon EFCC-UEMS Congress in October 2010. The videoconference was held with the participation of the Czech national society in Prague.
− The WG delivered two webinars: one on PSA testing, which was delivered by Elsevier and with the support of Beckman. The other was on Natriuretic Peptides and was delivered by Adobe and supported by Bio-Rad. A series of further webinars are being planned for 2011.
Highlights of EFCC educational and scientific events in 2010
EFCC and UEMS Boards celebrate the success of their first joint conference with the Best Poster Award Recipients and Augusto Machado, the key local organizer of the Congress Scientific sessions were delivered by clinicians and laboratory professionals in interactive sessions with lively debates about the pros and cons of topical problems related to laboratory medicine.
QUALITY MANAGEMENT COMMITTEE
− The Quality Management Committee collaborated with EDMA and the EU Commission working parties in revising the EU IVD Directive, with particular emphasis on "in house" assays [6] . The Committee issued statements with EDMA on diagnostic devices sold via the internet.
− An important landmark in the ongoing strong collaboration with the European cooperation for Accreditation (EA) was EFCC's official admission to Recognised Stakeholder Status in EA on 13 December 2010 [6] .
-The Accreditation/ISO-CEN WG continues effective collaboration with European Accreditation agency and ISO TC212 and CEN TC 140. The WG is involved in the revision of third edition of ISO 15189 and supports the implementation of the ISO 15189 standard.
-The Working Group collaborates with the EA Health Care Committee on assessor training.
-The WG is compiling guidance notes on the retention of documents in medical laboratories.
-A new survey has been prepared on critical value management in medical laboratories, in collaboration with AACB's harmonization group. The survey will be circulated in Europe in the second half of 2011.
-The Accreditation/ISO-CEN WG represented EFCC at the IFCC-ILAC talks and it was agreed that IFCC will seek collaboration and set up joint projects with EFCC on relevant accreditation matters.
-The IVD WG aims to support the interpretation and harmonisation of the use of the EU IVD Directive in laboratory practice and during accreditation of laboratories in Europe.
-The IVD WG represented EFCC in the European Commission "Exploratory process on medical devices" in its Workstream 3 expert group on "Competitiveness and innovation".
PROFESSIONAL COMMITTEE AND WG EC4 REGISTER COMMISSION
-The Committee and its WG operate the EC4 Register of European Specialists of Clinical Chemistry (www.ec4register.eu) which is separately administered and funded by the EC4 Foundation. At the end of 2010 there were 2116 registrants and efforts continue to encourage more. Much effort has been expended on encouraging registrants to re-register at the end of the five-year registration period, especially as the first group required to re-register for a second fiveyear period starts in January 2011. All EU countries, apart from Malta, which is a Corresponding Member, are now represented on the Register Commission.
-Equivalence of Standards proposals were approved for medical specialists in Lithuania, Sweden and Latvia. Twenty five countries now have approval (6 for medical specialists only) with only two countries still to submit any Equivalence of Standards.
-A pilot project to automatically register individuals who are on the Dutch national society (NVKC) register onto the EC4 Register was started in 2010 and should be completed early in 2011. A similar project is being designed for the UK subject to the agreement of ACB members.
-The Guide to the Register was updated and published in Clinical Chemistry and Laboratory Medicine [16] . A French version of the Code of Conduct was also published [17] .
-A small task group of National Representatives has been set up to revise the European Syllabus in 2011. It is planned to include competencies in the new version. − The EFCC website (www.efcclm.eu) has been modernised and updated and the new website will be released in May 2011 in Berlin.
-The official scientific journal of EFCC is Clinical Chemistry and Laboratory Medicine (CCLM). EFCC has signed an agreement with the Publisher, Walter de Gruyter & Co. KG, in 2010.
-EFCC also signed another agreement with the Clinical Chemistry Journal of AACC. Free annual subscriptions were granted to 10 professionals in less developed European countries. Educational materials of the journal have been promoted to EFCC national societies and at various EFCC events.
AWARDS
Nominations for EFCC's Roche Award to a clinical chemist who has made a major contribution to European Clinical Chemistry were sought from National Societies. The EFCC-Roche Scientific Award for Laboratory Medicine for 2011 will be awarded at the Worldlab/Euromedlab Congress in Berlin.
The EFCC-Abbott Labs are Vital Award for Excellence in Outcomes Research in Laboratory Medicine, was announced at Euromedlab in Innsbruck. The first award will be granted at the Worldlab/Euromedlab Congress 2011 in Berlin.
In sum, EFCC had a successful year in 2010 with lots of exciting scientific and professional events for which all EFCC officers, collaborative partners, the sponsors and EFCC's national society membership are highly commanded. We look forward to similarly successful collaborations in 2011! Andrea Rita Horvath President, EFCC 
